M. E. Franklin

465 total citations
10 papers, 323 citations indexed

About

M. E. Franklin is a scholar working on Infectious Diseases, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, M. E. Franklin has authored 10 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Infectious Diseases, 2 papers in Pharmacology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in M. E. Franklin's work include Pharmacological Effects and Toxicity Studies (2 papers), Renal and Vascular Pathologies (2 papers) and HIV/AIDS drug development and treatment (2 papers). M. E. Franklin is often cited by papers focused on Pharmacological Effects and Toxicity Studies (2 papers), Renal and Vascular Pathologies (2 papers) and HIV/AIDS drug development and treatment (2 papers). M. E. Franklin collaborates with scholars based in Australia and United States. M. E. Franklin's co-authors include W. D. Hooper, Thomas C. Chenier, R. S. Addison, Heather Cook, M. R. McCammon, R. G. Israel, Joseph A. Houmard, Lucille L. Smith, Jean Rosenbaum and W.J. Kolff and has published in prestigious journals such as The American Journal of Medicine, Epilepsia and Clinica Chimica Acta.

In The Last Decade

M. E. Franklin

10 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. E. Franklin Australia 7 94 58 58 53 49 10 323
Yanqing Liu China 10 24 0.3× 15 0.3× 53 0.9× 36 0.7× 268 5.5× 24 501
Louise Karlsson Sweden 14 92 1.0× 67 1.2× 91 1.6× 21 0.4× 40 0.8× 29 601
David O’Brien United Kingdom 12 20 0.2× 14 0.2× 23 0.4× 19 0.4× 50 1.0× 28 381
Geraldine Doyle United States 11 29 0.3× 29 0.5× 45 0.8× 11 0.2× 154 3.1× 15 394
Małgorzata Wilk Poland 11 25 0.3× 13 0.2× 5 0.1× 78 1.5× 8 0.2× 25 328
Andrew Brugger United States 8 12 0.1× 108 1.9× 33 0.6× 32 0.6× 225 4.6× 12 661
Shawn Flanagan United States 9 32 0.3× 21 0.4× 7 0.1× 8 0.2× 113 2.3× 19 426
Christine Richardson United States 13 13 0.1× 30 0.5× 7 0.1× 30 0.6× 12 0.2× 32 449
Nikolas P. Lemos United States 13 32 0.3× 41 0.7× 4 0.1× 28 0.5× 154 3.1× 20 533
Fikret Tüzün Türkiye 7 73 0.8× 12 0.2× 29 0.5× 7 0.1× 100 2.0× 8 456

Countries citing papers authored by M. E. Franklin

Since Specialization
Citations

This map shows the geographic impact of M. E. Franklin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. E. Franklin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. E. Franklin more than expected).

Fields of papers citing papers by M. E. Franklin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. E. Franklin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. E. Franklin. The network helps show where M. E. Franklin may publish in the future.

Co-authorship network of co-authors of M. E. Franklin

This figure shows the co-authorship network connecting the top 25 collaborators of M. E. Franklin. A scholar is included among the top collaborators of M. E. Franklin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. E. Franklin. M. E. Franklin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Taylor, Paul J., et al.. (2010). Therapeutic drug monitoring of immunosuppressant drugs by liquid chromatography–tandem mass spectrometry. Clinica Chimica Acta. 411(11-12). 904–904. 1 indexed citations
2.
Jacob, Siju Susan, M. E. Franklin, R. G. Dickinson, & W. D. Hooper. (2000). The Effect of Diflunisal on the Elimination of Triamterene in Human Volunteers. Drug metabolism and drug interactions. 16(3). 159–172. 5 indexed citations
3.
Addison, R. S., M. E. Franklin, & W. D. Hooper. (1998). Sensitive, high-throughput gas chromatographic–mass spectrometric assay for fluoxetine and norfluoxetine in human plasma and its application to pharmacokinetic studies. Journal of Chromatography B Biomedical Sciences and Applications. 716(1-2). 153–160. 24 indexed citations
4.
Franklin, M. E., et al.. (1998). Improved analytical procedure for the measurement of captopril in human plasma by gas chromatography–mass spectrometry and its application to pharmacokinetic studies. Journal of Chromatography B Biomedical Sciences and Applications. 705(1). 47–54. 46 indexed citations
5.
Hooper, W. D., M. E. Franklin, Paul Glue, et al.. (1996). Effect of Felbamate on Valproic Acid Disposition in Healthy Volunteers: Inhibition of β‐Oxidation. Epilepsia. 37(1). 91–97. 45 indexed citations
6.
Franklin, M. E., et al.. (1995). Effect of Positive Heel Inclination on Posture. Journal of Orthopaedic and Sports Physical Therapy. 21(2). 94–99. 66 indexed citations
7.
Bernus, I., R. G. Dickinson, W. D. Hooper, M. E. Franklin, & Mervyn J. Eadie. (1995). Effect of Felbamate on the Plasma Protein Binding of Valproate. Clinical Drug Investigation. 10(5). 288–295. 4 indexed citations
8.
Smith, Lucille L., Thomas C. Chenier, M. R. McCammon, et al.. (1993). The Effects of Static and Ballistic Stretching on Delayed Onset Muscle Soreness and Creatine Kinase. Research Quarterly for Exercise and Sport. 64(1). 103–107. 89 indexed citations
9.
Nakamoto, Satoru, et al.. (1962). Prolongation of survival by periodic prolonged hemodialysis in patients with chronic renal failure. The American Journal of Medicine. 33(4). 538–544. 25 indexed citations
10.
Franklin, M. E., et al.. (1961). Experience with A-V shunt cannulas for repeated dialyses.. PubMed. 7. 57–9. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026